ReviewTherapeutic advances in hematology2022

Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia.

Curtis A Lachowiez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.